FDA 483 - Robert Donald Harvey - March 24, 2017

The FDA inspected Robert Donald Harvey, a clinical investigator in Atlanta, GA, and issued a Form 483. The inspection revealed that nonclinical laboratory studies were not conducted according to the established protocol, specifically regarding the timing of chemistry and hematology safety labs for multiple subjects. This indicates a significant deviation from study procedures.